Assaf Harofeh; Oncology

Ẕerifin 6093000

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Transitional Cell, Colorectal Cancer, Triple-Negative Breast Cancer

Studies at this site

• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) — Completed
• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed